ciprofloxacin has been researched along with deferoxamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bentur, Y; Freedman, M; Klein, J; Koren, G; Leeder, JS; Tesoro, A | 1 |
| Ji, C; Miller, MJ | 1 |
| Badal, S; Her, YF; Maher, LJ | 1 |
| Gorgin Karaji, Z; Kazemi, MH; Sajadimajd, S | 1 |
1 review(s) available for ciprofloxacin and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for ciprofloxacin and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids.
Topics: Adolescent; Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Deferoxamine; Dogs; Humans; Thalassemia | 1989 |
Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Deferoxamine; Drug Delivery Systems; Esterases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrolysis; Microbial Sensitivity Tests; Phosphoric Monoester Hydrolases | 2012 |
Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Deferoxamine; Dioxygenases; DNA Methylation; Enrofloxacin; Epigenesis, Genetic; Fluoroquinolones; HEK293 Cells; Histones; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Iron; Iron Chelating Agents; Methylation; Mitogen-Activated Protein Kinase 8; Molecular Structure; Norfloxacin; Reverse Transcriptase Polymerase Chain Reaction | 2015 |
In vitro investigation of wound healing performance of PVA/chitosan/silk electrospun mat loaded with deferoxamine and ciprofloxacin.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Deferoxamine; Humans; Nanofibers; Polyvinyl Alcohol; Silk; Wound Healing | 2023 |